The National Kidney Foundation (NKF) 2026 Spring Clinical Meetings (SCM) will be held May 6 -10 at the New Orleans Ernest N. Morial Convention Center, bringing together kidney‑care professionals from across the country for practical education, clinical updates, and multidisciplinary collaboration. WashU Nephrology will be well represented this year by Anuja Java, MD, and Dr. Tingting Li, MD, MSCI, FASN, who are speaking across several high‑impact sessions, as well as nephrology fellows Ramayee Nadarajan, MD, and Abdulmoid Shehzad, MD, who, together with Morgan Schoer, MD, are presenting an abstract.
Dr. Java, associate professor of medicine and director of the Kidney Transplant Clinic at Veterans Affairs St. Louis Health Care System, will participate in the full‑day course Updates in the Approach to Management of Glomerular Disease (May 6), exploring the rapidly evolving landscape of glomerular disease, and will serve as a panelist at the Fellows Reception: Career Choices in Nephrology (May 6), offering fellows and trainees the opportunity to engage with nephrologists from a wide range of career paths.
She will speak in two scientific sessions: Advancing Glomerular Disease Care Through Biomarker Innovation (May 7), where she will present “Navigating Glomerular Disease with Complement Biomarkers: Diagnosis, Monitoring and Therapy;” and An Update on C3G and IC‑MPGN Management (May 8) session, where she will present “C3G and IC-MPGN: An Update on Classifications and Pathophysiology.”
Dr. Li, associate clinical chief in the Division of Nephrology, and director of the Glomerular Center of Excellence, will present in a session that will discuss current and emerging therapeutic approaches – Improving Outcomes in IgAN: Treating the Whole Patient (May 7) – where she will speak on “Comprehensive Care in IgA nephropathy (IgAN).”
Dr. Schoer, associate program director of our Nephrology Fellowship Program, and medical director of WashU Nephrology’s Home Modalities, and second-year fellows Dr. Nadarajan and Dr. Shehzad are presenting an abstract titled “Adjunctive Oral Vasopressor Strategy with Midodrine and Droxidopa Bridging from Terlipressin in Refractory Hepatorenal Syndrome” (May 7).
WashU Nephrology is proud to have our faculty and fellows sharing their expertise at SCM 2026, reflecting our division’s goal to advance patient‑centered kidney care.
Please follow @Ting2li and @anuja_java on X.
